Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development
Citations Over TimeTop 17% of 2014 papers
Abstract
Cocaine abuse is problematic, directly and indirectly impacting the lives of millions, and yet existing therapies are inadequate and usually ineffective. A cocaine vaccine would be a promising alternative therapeutic option, but efficacy is hampered by variable production of anticocaine antibodies. Thus, new tactics and strategies for boosting cocaine vaccine immunogenicity must be explored. Flagellin is a bacterial protein that stimulates the innate immune response via binding to extracellular Toll-like receptor 5 (TLR5) and also via interaction with intracellular NOD-like receptor C4 (NLRC4), leading to production of pro-inflammatory cytokines. Reasoning that flagellin could serve as both carrier and adjuvant, we modified recombinant flagellin protein to display a cocaine hapten termed GNE. The resulting conjugates exhibited dose-dependent stimulation of anti-GNE antibody production. Moreover, when adjuvanted with alum, but not with liposomal MPLA, GNE-FliC was found to be better than our benchmark GNE-KLH. This work represents a new avenue for exploration in the use of hapten-flagellin conjugates to elicit antihapten immune responses.
Related Papers
- → Helicobacter pyloriFlagellin Evades Toll‐Like Receptor 5–Mediated Innate Immunity(2004)285 cited
- → Amino acids 89–96 of Salmonella typhimurium flagellin represent the major domain responsible for TLR5-independent adjuvanticity in the humoral immune response(2014)25 cited
- → Role of translocated bacterial flagellin in monocyte activation among individuals with chronic HIV-1 infection(2015)12 cited
- Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice(2015)
- → Flagellin positively and negatively regulates IL‐1β expression via Ipaf and TLR5(2009)